Integrative data-intensive approaches to drug design

28. July 2022

The 23rd EuroQSAR Symposium will take place in Heidelberg, chaired by HITS group leader Rebecca Wade. Deadline for abstract submission: 4 August 2022

From 26-30 September 2022, the 23rd European Symposium on Quantitative Structure-Activity Relationship (QSAR) will take place in Heidelberg. It is entitled “Integrative Data-Intensive Approaches to Drug Design” and chaired by HITS group leader Rebecca Wade (MCM).

The scientific programme of the Symposium will include 12 plenary lectures, 20 session lectures, 7 oral communications, company workshops, poster presentations and a commercial exhibition.

The submission deadline for poster presentations is 4 August 2022.

The EuroQSAR Symposia have been taking place since 1973 and constitute major scientific events in the field of computational drug design, with further applications in agricultural and environmental sciences.

About HITS

The Heidelberg Institute for Theoretical Studies (HITS) was established in 2010 by the physicist and SAP co-founder Klaus Tschira (1940-2015) and the Klaus Tschira Foundation as a private, non-profit research institute. HITS conducts basic research in the natural sciences, mathematics and computer science, with a focus on the processing, structuring, and analyzing of large amounts of complex data and the development of computational methods and software. The research fields range from molecular biology to astrophysics. The shareholders of HITS are the HITS-Stiftung, which is a subsidiary of the Klaus Tschira Foundation, Heidelberg University and the Karlsruhe Institute of Technology (KIT). HITS also cooperates with other universities and research institutes and with industrial partners. The base funding of HITS is provided by the HITS Stiftung with funds received from the Klaus Tschira Foundation. The primary external funding agencies are the Federal Ministry of Education and Research (BMBF), the German Research Foundation (DFG), and the European Union.

Switch to the German homepage or stay on this page